skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Patent ·
OSTI ID:1178261

The present invention relates to nucleic acids encoding mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids of the invention are suitable for use in inducing an immune response to HIV-1 in a human.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
Los Alamos National Security, LLC (Los Alamos, NM)
Patent Number(s):
9,011,873
Application Number:
13/094,734
OSTI ID:
1178261
Resource Relation:
Patent File Date: 2011 Apr 26
Country of Publication:
United States
Language:
English

References (37)

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates journal January 2014
Toward an AIDS Vaccine journal May 2008
The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years journal September 2005
Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice journal September 2004
Evolutionary and immunological implications of contemporary HIV-1 variation journal September 2001
Diversity Considerations in HIV-1 Vaccine Selection journal June 2002
HIV vaccine strategies journal February 2002
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus journal November 2002
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants journal December 2006
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity journal January 2006
Prospects for an AIDS vaccine journal March 2004
Progress and obstacles in the development of an AIDS vaccine journal December 2006
HIV VACCINES journal December 2005
Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope journal August 2005
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice journal February 1998
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys journal February 2010
Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination journal December 2008
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys journal February 2010
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces journal May 2009
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys journal July 2008
Ancestral and COT viral sequences, proteins and immunogenic compositions patent February 2010
Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens patent May 2011
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins patent February 2012
Antigen Library Immunization patent-application December 2002
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications patent-application March 2003
Method for the development of an HIV vaccine patent-application June 2003
Polyvalent immunogen patent-application August 2003
Immunogenic, cross-clade, HIV peptides patent-application September 2003
Peptide compositions for the treatment and prevention of HIV infection patent-application October 2003
Polyvalent immunogen patent-application January 2004
Ancestral and COT viral sequences, proteins and immunogenic compositions patent-application June 2005
Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use patent-application September 2006
HIV vaccines based on Env of multiple clades of HIV patent-application December 2006
Consensus/ancestral immunogens patent-application August 2007
Polyvalent Vaccine patent-application December 2009
Polyvalent Vaccine patent-application June 2011
Polyvalent Vaccine patent-application May 2012